Company intelligence / Profile preview

Lachesis Biosciences

Melbourne, Victoria, Australialachesisbiosciences.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Lachesis Biosciences is a clinical-stage biotech company developing pro-cognitive pharmaceuticals using its patented nasal spray technology to improve treatment of neurodegenerative diseases. Its lead candidate, a rivastigmine nasal spray, has completed proof-of-concept and initial manufacturing studies. The company plans pivotal efficacy and safety trials in Alzheimer's patients. Early data suggest improved bioavailability over oral or patch forms, potentially offering better tolerability and faster onset. The approach leverages an expedited regulatory pathway due to the established efficacy of the active ingredient.

Therapeutic areas: Neurology
Modalities: Reformulated small molecules (notably rivastigmine)Nasal spray drug delivery technology
Industry: Biotech

Drug pipeline

1 asset

rivastigmine

Phase 1

Indications: Alzheimer's disease, Parkinson's disease

Beyond the preview

Go deeper on Lachesis Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lachesis Biosciences.

Explore the full profile